Friday 28th April 2017
The Oxford Science Park will be again exhibiting at BioTrinity 2017, Europe’s leading Biopartnering and Investment conference, to be held on 8 – 10 May at the Novotel London West.
Founded and produced by OBN, BioTrinity is now in its 11th year. BioTrinity continues to grow with more than 1,000 senior executives and decision makers from emerging and established companies across the life sciences’ sector and investment firms are expected to attend.
Piers Scrimshaw-Wright, Managing Director, The Oxford Science Park said: “Every year OBN attracts a great gathering of the life sciences’ community and investors. We will be taking the Park to London, showcasing not just our thriving community and commercial ecosystem, but also Oxford as the heart of scientific endeavour.
“This year we will be proudly featuring The Schrödinger Building, our state of the art, brand new office and lab building. Due for completion in Spring 2018 it will house up to 500 employees providing the much-needed science and technology growth space.”
John Harris, CEO, OBN, said: “We are delighted that The Oxford Science Park will be again exhibiting at BioTrinity this year. BioTrinity is the perfect platform for life science companies to showcase their innovation and seek out their next deal. This year again we are thrilled to be hosting what we believe will be the great business development opportunity of 2017.”
Visit The Oxford Science Park at BioTrinity 2017, located at stand 31.
Visit BioTrinity’s website for more information.